Hybridoma · 1991 · 29 citations · 17 references
PharmacyImmunologyInfectious DiseasesImmunizationMonoclonal AntibodiesVaccinologyAntibody CharacterizationAntibody FunctionAntibody PurificationAntibody-mediated ProtectionMonoclonal Antibody TechnologyTherapeutic Monoclonal AntibodiesAnimal ImmunizationAntibodiesMonoclonal Antibody TherapeuticsMyeloma Cell LinesRabies ImmunoprophylaxisRabies VaccinesRabies VirusWestern Blot Analysis
According to a recommendation from WHO (World Health Organisation) for prevention of a possible rabies infection, active vaccination has to be combined with application of immunoglobulin to get a fast protective effect. At present, preparations of purified human or equine rabies-specific immunoglobulin are used. We have generated a human rabies-specific monoclonal antibody (huMAb) by immortalization of human B-cells with Epstein Barr Virus (EBV), followed by fusion with a mouse myeloma cell. The resulting clone TW-1 secrets an IgG1 lambda huMAb which specifically reacts in ELISA with 5 laboratory rabies virus strains of serotype 1 and DUV3 (Duvenhage, serotype 4). Western Blot analysis revealed fine specificity for the G glycoprotein (gp67) of rabies virus. HuMAb TW-1 neutralizes rabies virus in vitro (RFFIT) as well as in vivo and protects rabies infected mice. Compared to polyclonal human rabies immunoglobulins, huMAb TW-1 is advantageous, because of its defined specificity and the very low amounts of total protein needed for therapeutic effects.
17
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Bulletin of the World Health Organization
N. H. C. · British Journal of Sociology · 1955 · 3.7K citations